wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37977335-0CA0E1A7-4EFF-4139-AC36-4457C8BFE887
Q37977335-0CA0E1A7-4EFF-4139-AC36-4457C8BFE887
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37977335-0CA0E1A7-4EFF-4139-AC36-4457C8BFE887
The alpha-cell as target for type 2 diabetes therapy.
P2860
Q37977335-0CA0E1A7-4EFF-4139-AC36-4457C8BFE887
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37977335-0CA0E1A7-4EFF-4139-AC36-4457C8BFE887
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
69fbba8832e3fa92e8bb3f0f8db7e3ec49947d83
P2860
One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and alpha- and beta-cell function and reduces endogenous glucose release in patients with type 2 diabetes.